Literature DB >> 28666145

Simple and effective generation of transgene-free induced pluripotent stem cells using an auto-erasable Sendai virus vector responding to microRNA-302.

Ken Nishimura1, Manami Ohtaka2, Hitomi Takada2, Akira Kurisaki2, Nhi Vo Kieu Tran1, Yen Thi Hai Tran1, Koji Hisatake1, Masayuki Sano3, Mahito Nakanishi4.   

Abstract

Transgene-free induced pluripotent stem cells (iPSCs) are valuable for both basic research and potential clinical applications. We previously reported that a replication-defective and persistent Sendai virus (SeVdp) vector harboring four reprogramming factors (SeVdp-iPS) can efficiently induce generation of transgene-free iPSCs. This vector can express all four factors stably and simultaneously without chromosomal integration and can be eliminated completely from reprogrammed cells by suppressing vector-derived RNA-dependent RNA polymerase. Here, we describe an improved SeVdp-iPS vector (SeVdp(KOSM)302L) that is automatically erased in response to microRNA-302 (miR-302), uniquely expressed in pluripotent stem cells (PSCs). Gene expression and genome replication of the SeVdp-302L vector, which contains miRNA-302a target sequences at the 3' untranslated region of L mRNA, are strongly suppressed in PSCs. Consequently, SeVdp(KOSM)302L induces expression of reprogramming factors in somatic cells, while it is automatically erased from cells successfully reprogrammed to express miR-302. As this vector can reprogram somatic cells into transgene-free iPSCs without the aid of exogenous short interfering RNA (siRNA), the results we present here demonstrate that this vector may become an invaluable tool for the generation of human iPSCs for future clinical applications.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell reprogramming; Induced pluripotent stem cell; MicroRNA; Sendai virus

Mesh:

Substances:

Year:  2017        PMID: 28666145     DOI: 10.1016/j.scr.2017.06.011

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  16 in total

Review 1.  An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.

Authors:  Manash P Borgohain; Krishna Kumar Haridhasapavalan; Chandrima Dey; Poulomi Adhikari; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

Review 2.  Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story.

Authors:  Gabrielle Mangin; Nathalie Kubis
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

Review 3.  Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave.

Authors:  Brenna Sharp; Ramya Rallabandi; Patricia Devaux
Journal:  Mol Diagn Ther       Date:  2022-06-28       Impact factor: 4.476

4.  Generation and characterization of motor neuron progenitors and motor neurons using metachromatic leukodystrophy-induced pluripotent stem cells.

Authors:  Mohammad Arif Hossain; Minami Hasegawa-Ogawa; Yoko Manome; Miki Igarashi; Chen Wu; Ken Suzuki; Junko Igarashi; Takeo Iwamoto; Hirotaka James Okano; Yoshikatsu Eto
Journal:  Mol Genet Metab Rep       Date:  2022-02-21

5.  Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains.

Authors:  Gabriel E Hoffman; Brigham J Hartley; Erin Flaherty; Ian Ladran; Peter Gochman; Douglas M Ruderfer; Eli A Stahl; Judith Rapoport; Pamela Sklar; Kristen J Brennand
Journal:  Nat Commun       Date:  2017-12-20       Impact factor: 14.919

6.  Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector.

Authors:  Takashi Okumura; Yumi Horie; Chen-Yi Lai; Huan-Ting Lin; Hirofumi Shoda; Bunki Natsumoto; Keishi Fujio; Eri Kumaki; Tsubasa Okano; Shintaro Ono; Kay Tanita; Tomohiro Morio; Hirokazu Kanegane; Hisanori Hasegawa; Fumitaka Mizoguchi; Kimito Kawahata; Hitoshi Kohsaka; Hiroshi Moritake; Hiroyuki Nunoi; Hironori Waki; Shin-Ichi Tamaru; Takayoshi Sasako; Toshimasa Yamauchi; Takashi Kadowaki; Hiroyuki Tanaka; Sachiko Kitanaka; Ken Nishimura; Manami Ohtaka; Mahito Nakanishi; Makoto Otsu
Journal:  Stem Cell Res Ther       Date:  2019-06-24       Impact factor: 6.832

7.  Induction of integration-free human-induced pluripotent stem cells under serum- and feeder-free conditions.

Authors:  Atsuko Hamada; Eri Akagi; Sachiko Yamasaki; Hirotaka Nakatao; Fumitaka Obayashi; Manami Ohtaka; Ken Nishimura; Mahito Nakanishi; Shigeaki Toratani; Tetsuji Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-11-25       Impact factor: 2.416

8.  Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers.

Authors:  Tadahiro Honda; Miki Ando; Jun Ando; Midori Ishii; Yumi Sakiyama; Kazuo Ohara; Tokuko Toyota; Manami Ohtaka; Ayako Masuda; Yasuhisa Terao; Mahito Nakanishi; Hiromitsu Nakauchi; Norio Komatsu
Journal:  Mol Ther       Date:  2020-07-09       Impact factor: 11.454

9.  Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy.

Authors:  Christopher Horton; Timothy J Davies; Priyoshi Lahiri; Patty Sachamitr; Paul J Fairchild
Journal:  Stem Cells       Date:  2019-10-31       Impact factor: 6.277

10.  Induction of Noonan syndrome-specific human-induced pluripotent stem cells under serum-, feeder-, and integration-free conditions.

Authors:  Atsuko Hamada; Eri Akagi; Fumitaka Obayashi; Sachiko Yamasaki; Koichi Koizumi; Manami Ohtaka; Ken Nishimura; Mahito Nakanishi; Shigeaki Toratani; Tetsuji Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-11-02       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.